Chloroquine differentially modulates coronary vasodilation in control and diabetic mice
British Journal of Pharmacology2019Vol. 177(2), pp. 314–327
Citations Over TimeTop 25% of 2019 papers
Qian Zhang, Atsumi Tsuji‐Hosokawa, Conor Willson, Makiko Watanabe, Rui Si, Ning Lai, Ziyi Wang, Jason X.‐J. Yuan, Jian Wang, Ayako Makino
Abstract
These data indicate that chloroquine affects vascular relaxation differently under normal and diabetic conditions. Therefore, the patients' health condition such as coronary macrovascular or microvascular disease, with or without diabetes, must be taken account into the consideration when selecting chloroquine for the treatment of malaria.
Related Papers
- → Differential response to myocardial reperfusion injury in eNOS-deficient mice(2002)94 cited
- → Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells(2010)60 cited
- → CHLOROQUINE RESISTANCE IN MALARIA: A DEFICIENCY OF CHLOROQUINE BINDING(1969)130 cited
- → Effects of resveratrol on endothelial nitric oxide synthase (eNOS) phosphorylation and interaction with regulatory proteins(2008)1 cited
- Interaction between regulatory proteins related to the activation of eNOS and CYP4A/20-HETE(2007)